Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.76 USD | +3.70% | -3.76% | -31.91% |
04-15 | Intellia Therapeutics, Inc. Appoints Michael P. Dube as Principal Accounting Officer | CI |
03-25 | Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals | MT |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.